Astrocytic GLUT1 & Glucose Uptake
We study how GLUT1 deficiency specifically in astrocytes contributes to Alzheimer-like neurodegeneration independently of cerebrovascular alterations.
through glial biology
Exploring how astrocytic metabolic signalling shapes the neuronal environment in the early stages of neurodegeneration.
A leading neurodegenerative disorder emerging within a paradoxical metabolic landscape where energy demand rises but supply falters.
Strategically positioned between blood vessels and neurons, astrocytes are energy sensors that can become maladaptive, fueling neuroinflammation.
A multicellular enterprise — energetically and redox integrated across cell types — far surpassing the traditional neuron-centric lens.
We study how GLUT1 deficiency specifically in astrocytes contributes to Alzheimer-like neurodegeneration independently of cerebrovascular alterations.
We explore how astrocytes undergo metabolic reprogramming in early stages, potentially accumulating excess glycogen, precipitating the disease cascade.
Investigating whether VEGF administration can rescue cognitive deficits in AD mouse models lacking astrocytic GLUT1, opening new treatment avenues.
Identifying metabolic markers in cerebrospinal fluid and blood that signal early astrocyte dysfunction before symptom onset.
Designing and synthesising multitarget compounds — including H3R antagonists and AChE inhibitors — inspired by known AD frameworks.
Examining how insulin signalling failure in the brain contributes to energy dysfunction and accelerates AD progression.
Completed
Cerebral blood vessels are composed of endothelial cells that interact closely with astrocytes, regulating the transport of nutrients such as…
€196.262
Completed
This project investigates how insulin resistance in the brain may link age-related diseases such as type 2 diabetes and Alzheimer’s…
€63.000
Completed
The availability of glucose in the central nervous system is essential for neuronal function, and brain glucose levels have been…
€190.000
Active
The crucial role of brain insulin action in the regulation of systemic metabolism, energy balance, and glucose homeostasis, as well…
€312.500
Active
Astrocytes are brain cells that help, support and protect neurons, ensuring the brain functions properly by providing energy and defending…
€800.000
Active
Alzheimer's disease (AD) represents a growing public health challenge, with its prevalence steadily increasing profoundly affecting both patients and their…
€2.000.000Alzheimer's disease (AD), the leading neurodegenerative disorder linked to aging, emerges within a paradoxical metabolic landscape. Despite rising cellular energy demands due…
View paper →This editorial challenges the long‐held neuron‐centered view of brain metabolism, relying on ample evidence that it is a cooperative, multicellular process. Astrocytes,…
View paper →Alzheimer’s disease (AD) is a complex and multifactorial neurodegenerative disorder characterized by cognitive decline, memory loss, behavioral changes, and other neurological symptoms.…
View paper →Trimethylamine N-oxide (TMAO) is a molecule generated from choline, betaine, and carnitine via gut microbial metabolism. The plasma level of TMAO is…
View paper →
Maite Solas, a researcher at the University of Navarra Faculty of Pharmacy and Nutrition, has received the Pasqual Maragall Researchers Programme grant…
Read more →
Maite Solas focuses her research on detecting early changes in Alzheimer's Disease and finding ways to slow its progression. Her work studies…
Read more →
Maite Solas, a researcher and professor in the Department of Pharmaceutical Sciences at the University of Navarra, has received a grant from…
Read more →We are always looking for motivated students, postdocs, and collaborators passionate about neuroscience and brain metabolism. Reach out — good conversations start with a good hypothesis.